跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 8,444 条关于
“residual paralysis”
全部
8,444
临床试验
6,817
药物
5
机构
7
资讯
1,615
去年
Senzime Secures Major U.S. Hospital Contract and New Patent for TetraGraph Neuromuscular Monitoring System
5年前
Advancements in Minimal Residual Disease Assessment Transforming Myeloma Treatment
2年前
Pre-Transplant MRD Status Significantly Impacts Survival Outcomes in AML and MDS Patients
2年前
MRD Negativity Predicts PFS in Multiple Myeloma: Meta-Analysis Supports Accelerated Drug Approval
9年前
MRD Negativity Predicts Superior Survival in Multiple Myeloma Patients
2年前
ctDNA Analysis Predicts Survival and Treatment Response in Colorectal Cancer
6年前
MRD Negativity as a Surrogate Endpoint for PFS in Multiple Myeloma
6年前
MRD Negativity as a Surrogate Endpoint for PFS in Newly Diagnosed Multiple Myeloma
去年
NervGen Pharma Highlights Clinical Trial Challenges in Spinal Cord Injury at U2FP Symposium
去年
ReNetX Bio's Spinal Cord Injury Treatment Faces Policy Hurdles Despite Promising Clinical Signs
第 1 页,共 162 页
上一页
下一页